GE11 多肽


  • 产品名称
    GE11 多肽
  • 序列
  • 三字母序列
  • 长度 (aa)
  • 多肽纯度 (HPLC)
  • 分子式
  • 分子量
  • 来源
  • 描述
    EGFR is a crucial driver of tumorigenesis abundantly overexpressed, amplified or mutated in many cancers including lung and breast cancers, and glioblastomas. EGFR overexpression or mutation often correlate with drug resistance thereby presenting EGFR as a possible target in many malignant tumors. For the identification of EGFR binding peptides, T7 phage displayed peptide library was incubated with the purified human EGFR. After three rounds of panning, the dodecapeptide termed GE11 (YHWYGYTPQNVI) was shown to bind specifically to EGFR. The peptide showed high binding affinity in nanomolar range (KD = approximately 22 nM) that could be inhibited by EGF, indicating that they bound to the same site on EGFR. In vivo targeting ability of the radioactively labeled 125I-GE11 peptide was validated after intravenous (i.v.) infusion of the conjugate into nude mice bearing subcutaneous hepatocellular carcinoma (SMMC-7721) xenografts. The tumor targeting of 125I-GE11 was inhibited by a 100-fold excess of cold GE11 peptide. In addition, GE11 peptide was used as a gene delivery vehicle upon conjugation to the polyethylenimine (PEI) polyplexes using a glycine (G-G-G-S) linker system and intravenously administered to the SMMC-7721 bearing mice. Cheng and colleagues reported the conjugation of GE11 to Doxil for targeted in vivo delivery to EGFR-overexpressing non-small cell lung cancer (A549). Doxil (PEGylated liposomal Dox, PEG-LP/Dox, or non-PEGylated Dox, LP/Dox) is an FDA approved chemotherapy comprising doxorubicin drug encapsulated in liposomes. Doxil, also referred to as Lipo-Dox, is widely used in the clinics for ovarian cancer treatment. Very promising results were obtained when the GE11-conjugated doxorubicin filled liposomes (GE11-PS-Dox) were used to treat ovarian cancer xenograft bearing mice, indicating GE11-guided drug targeting as an alternative for treatment of EGFR overexpressing ovarian cancers. GE11-PS-Dox treatment very significantly increased the survival rate with minimal toxicity compared to non-targeting control (PS-Dox) or the clinically used Lipo-Dox. In a similar fashion, GE11-PS-Dox also showed prolonged survival compared to the PBS- and non-targeting treatment controls (PS-Dox, Lipo-Dox) in a preclinical liver cancer treatment study. Moreover, several GE11-targeted radionuclides have been studied in imaging of EGFR overexpressing tumors with either PET or SPECT.
  • 储存指南
    一般情况下, GE11 多肽 粉末应该保存在-20甚至-70摄氏度. GE11 多肽 溶解后应该-70摄氏度分装保存,避免反复冻融. 了解更多细节,请查阅手册:多肽溶解及保存指南
  • 参考文献
    • Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 2005;19(14):1978-85
  • 关于三氟乙酸盐




    • 将用于细胞试验的多肽
    • 将被用作原料药或制成品的多肽
    • 含有大量碱性残基的亲水多肽

  • 关于多肽净含量



  • 分子式:C75H97N17O19
  • 长度:12
  • 消光系数:9530 M-1cm-1
  • GRAVY:-0.75
  • 分子量:1540.67
  • 理论pI:7.66
  • 数据来源:多肽性质计算器

GRAVY = 平均疏水性(grand average of hydropathy)

X: 疏水不带电残基,如 F I L M V W A 和 P

X: 碱性残基,如 R K H

X: 酸性残基,如 D E

X: 极性不带电残基,如 G S T C N Q 和 Y

多肽合成服务: 纽普生物(NovoPro)提供常规多肽合成、糖修饰多肽合成、稳定同位素标记的多肽合成、磷酸化多肽合成、荧光标记多肽、多肽的BSA/KLH/OVA等载体蛋白的偶联等服务